Updated Results from the Phase Ib/II Study of Fruquintinib Combined with SOX and Toripalimab in Patients with Advanced Metastatic Gastric/gastroesophageal Junction Adenocarcinoma (GC/GEJC).
Journal of Clinical Oncology（2025）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined